| 发明名称 |
PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES |
| 摘要 |
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R1-R9 and R12-R14 are as defined herein; |
| 申请公布号 |
US2014303182(A1) |
申请公布日期 |
2014.10.09 |
| 申请号 |
US201414215437 |
申请日期 |
2014.03.17 |
| 申请人 |
Cai Shaopei;Chou Joyce;Harwood Eric;Machajewski Timothy;Ryckman David;Shang Xiao;Zhu Shuguang;Okhamate Augustus;Tesconi Marc S. |
发明人 |
Cai Shaopei;Chou Joyce;Harwood Eric;Machajewski Timothy;Ryckman David;Shang Xiao;Zhu Shuguang;Okhamate Augustus;Tesconi Marc S. |
| 分类号 |
C07D401/04 |
主分类号 |
C07D401/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A lactate salt of 4-amino-5-tluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one. |
| 地址 |
Seattle WA US |
